Latest News
Biodesix, Inc.
- H.C. Wainwright reiterates Biodesix stock rating on lung nodule framework By Investing.com
- Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026
- Biodesix Advances Tumor-Informed and Tumor-Naïve MRD Assays
- Biodesix Partners With Vanderbilt to Develop Lung Cancer Risk Test Combining Blood Tests and Imaging
- Biodesix adds digital diagnostics to lung testing platform By Investing.com
- Biodesix adds lung imaging test to pipeline with 2028 launch target
- Biodesix - Adds Digital Diagnostics To Lung Diagnostics Strategy
- Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers
- Form 4 Biodesix Inc: John Patience (Director, Chairman) For: 30 September
- Biodesix Drawing on Partnerships to Develop Decentralized Minimal Residual Disease Assays
- Biodesix to Present New Real-World Evidence Supporting Integration of Nodify Lung® Testing into Routine Lung Nodule Care at CHEST 2026
- Biodesix advances MRD testing programs with Bio-Rad, Thermo Fisher
Headlines from the last 30 days, linking to the original publishers. See all market news →